Sublingual versus subcutaneous immunotherapy in children with asthma or rhinitis as a result of house dust mite sensitivity
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2010
At a glance
- Drugs House dust mite allergy immunotherapy (Primary) ; House dust mite allergy immunotherapy injection ALK Abello (Primary)
- Indications Allergic asthma; Allergic rhinitis
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.